The effects of valproic acid and levetiracetam treatments on kidney functions in children with epilepsy.

IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Nesrin Tas, Ozge Balci, Mehmet Senes, Sukran Bicakci, Arzu Yılmaz
{"title":"The effects of valproic acid and levetiracetam treatments on kidney functions in children with epilepsy.","authors":"Nesrin Tas, Ozge Balci, Mehmet Senes, Sukran Bicakci, Arzu Yılmaz","doi":"10.12669/pjms.41.4.10385","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Clinical and subclinical evidence of kidney dysfunction has been reported with the use of some anti-epileptic drugs (AEDs) in children. This study aimed to evaluate renal tubular and glomerular functions using novel biomarkers N-acetyl-β-d-glycosaminidase (NAG), Kidney Injury Molecule-1(KIM-1) and 24-hour measured creatinine clearance (mCl<sub>cr</sub>) in patients taking valproic acid (VPA) and levetiracetam (LEV).</p><p><strong>Methods: </strong>Fifty-one epileptic patients were included in this prospective case-control study between January 2023 and January 2024 in The Ankara Training and Research Hospital. Exclusions were made for individuals on multiple AEDs, those with incomplete data, bedridden patients, concurrent conditions (hypertension, obesity), or those using steroids or other medications. Participants had been on either VPA or LEV for at least six months. Sixteen healthy age- and sex-matched children served as the control group. Blood samples and 24-hour urine NAG, KIM-1, and mClcr measurements were collected.</p><p><strong>Results: </strong>The VPA, LEV, and control group comprised 30, 21, and 16 patients, respectively. The VPA group had higher urinary pH (6.1±0.7) and mCl<sub>cr</sub> levels (173.4±48.0) than LEV (5.6±0.5, 149.7±39.1) and control (5.6±0.6, 130.6±30.6) groups. No significant difference was observed in urinary pH and mCl<sub>cr</sub> levels between the LEV and control groups <i>(p>0.05)</i>. No statistically significant differences were observed among the VPA, LEV, and control groups regarding 24-hour urinary NAG, KIM-1, NAG/creatinine, and KIM-1/creatinine levels <i>(p>0.05)</i>. There was no significant association between mCl<sub>cr</sub> levels and duration of treatment or serum drug levels on Spearman's correlation coefficient <i>(p>0.05)</i>.</p><p><strong>Conclusion: </strong>We found VPA-associated glomerular hyperfiltration in children with epilepsy. We did not observe tubular dysfunction in patients on VPA or LEV.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"41 4","pages":"997-1002"},"PeriodicalIF":1.2000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12022592/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12669/pjms.41.4.10385","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Clinical and subclinical evidence of kidney dysfunction has been reported with the use of some anti-epileptic drugs (AEDs) in children. This study aimed to evaluate renal tubular and glomerular functions using novel biomarkers N-acetyl-β-d-glycosaminidase (NAG), Kidney Injury Molecule-1(KIM-1) and 24-hour measured creatinine clearance (mClcr) in patients taking valproic acid (VPA) and levetiracetam (LEV).

Methods: Fifty-one epileptic patients were included in this prospective case-control study between January 2023 and January 2024 in The Ankara Training and Research Hospital. Exclusions were made for individuals on multiple AEDs, those with incomplete data, bedridden patients, concurrent conditions (hypertension, obesity), or those using steroids or other medications. Participants had been on either VPA or LEV for at least six months. Sixteen healthy age- and sex-matched children served as the control group. Blood samples and 24-hour urine NAG, KIM-1, and mClcr measurements were collected.

Results: The VPA, LEV, and control group comprised 30, 21, and 16 patients, respectively. The VPA group had higher urinary pH (6.1±0.7) and mClcr levels (173.4±48.0) than LEV (5.6±0.5, 149.7±39.1) and control (5.6±0.6, 130.6±30.6) groups. No significant difference was observed in urinary pH and mClcr levels between the LEV and control groups (p>0.05). No statistically significant differences were observed among the VPA, LEV, and control groups regarding 24-hour urinary NAG, KIM-1, NAG/creatinine, and KIM-1/creatinine levels (p>0.05). There was no significant association between mClcr levels and duration of treatment or serum drug levels on Spearman's correlation coefficient (p>0.05).

Conclusion: We found VPA-associated glomerular hyperfiltration in children with epilepsy. We did not observe tubular dysfunction in patients on VPA or LEV.

丙戊酸与左乙拉西坦治疗对癫痫患儿肾功能的影响。
目的:已经报道了一些抗癫痫药物(aed)在儿童中引起肾功能障碍的临床和亚临床证据。本研究旨在利用新型生物标志物n -乙酰-β-d-糖胺苷酶(NAG)、肾损伤分子-1(KIM-1)和24小时肌酸酐清除率(mClcr)评估服用丙戊酸(VPA)和左乙莱西坦(LEV)患者的肾小管和肾小球功能。方法:2023年1月至2024年1月在安卡拉培训与研究医院进行的前瞻性病例对照研究纳入51例癫痫患者。排除了使用多种aed的患者、数据不完整的患者、卧床不起的患者、并发疾病(高血压、肥胖)或使用类固醇或其他药物的患者。参与者使用VPA或LEV至少6个月。16名年龄和性别匹配的健康儿童作为对照组。采集血样和24小时尿液NAG、KIM-1和mClcr测量值。结果:VPA组30例,LEV组21例,对照组16例。VPA组尿pH值(6.1±0.7)和mClcr(173.4±48.0)高于LEV组(5.6±0.5,149.7±39.1)和对照组(5.6±0.6,130.6±30.6)。LEV组与对照组尿pH、mccr水平差异无统计学意义(p < 0.05)。VPA组、LEV组和对照组24小时尿NAG、KIM-1、NAG/肌酐、KIM-1/肌酐水平差异无统计学意义(p < 0.05)。mccr水平与治疗时间及血清药物水平对Spearman相关系数无显著相关性(p < 0.05)。结论:在癫痫患儿中发现与vpa相关的肾小球高滤过。我们没有观察到VPA或LEV患者的小管功能障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pakistan Journal of Medical Sciences
Pakistan Journal of Medical Sciences 医学-医学:内科
CiteScore
4.10
自引率
9.10%
发文量
363
审稿时长
3-6 weeks
期刊介绍: It is a peer reviewed medical journal published regularly since 1984. It was previously known as quarterly "SPECIALIST" till December 31st 1999. It publishes original research articles, review articles, current practices, short communications & case reports. It attracts manuscripts not only from within Pakistan but also from over fifty countries from abroad. Copies of PJMS are sent to all the import medical libraries all over Pakistan and overseas particularly in South East Asia and Asia Pacific besides WHO EMRO Region countries. Eminent members of the medical profession at home and abroad regularly contribute their write-ups, manuscripts in our publications. We pursue an independent editorial policy, which allows an opportunity to the healthcare professionals to express their views without any fear or favour. That is why many opinion makers among the medical and pharmaceutical profession use this publication to communicate their viewpoint.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信